6BR6
N2 neuraminidase in complex with a novel antiviral compound
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX1 |
Synchrotron site | Australian Synchrotron |
Beamline | MX1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2017-06-17 |
Detector | ADSC QUANTUM 210r |
Wavelength(s) | 0.979 |
Spacegroup name | P 4 21 2 |
Unit cell lengths | 108.457, 108.457, 70.204 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 48.503 - 2.040 |
R-factor | 0.175912955444 |
Rwork | 0.173 |
R-free | 0.22463 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.009 |
RMSD bond angle | 1.009 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHENIX |
Refinement software | PHENIX (1.12_2829) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 48.504 | 2.100 |
High resolution limit [Å] | 2.039 | 2.040 |
Rmerge | 0.213 | 1.388 |
Rmeas | 0.218 | 1.428 |
Rpim | 0.050 | 0.330 |
Number of reflections | 27261 | 2037 |
<I/σ(I)> | 12.2 | 2.5 |
Completeness [%] | 99.8 | 97.9 |
Redundancy | 19.1 | 18 |
CC(1/2) | 0.890 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 8 | 293 | 0.1M Tris, pH 8.0 20% PEG 400 |